← All trials
NCT04688398
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 11, 2021
- Primary completion
- Jun 30, 2022
- Completion date
- Sep 30, 2022
- First posted
- Dec 30, 2020
- Last posted
- Dec 30, 2020
- Enrollment
- 130
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Laval UniversityLead sponsor
- Government of QuebecCollaborator
- Laval UniversityReponsible party - principal investigator
- Laval UniversityOverall official - principal investigator
- Groupe De Recherche En Rhumatologie Et Maladies Osseuses Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.